Trial Profile
Multicenter phase 2 clinical trial of tailored therapy according to MGMT methylation status for elderly glioblastoma patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- Acronyms EGG
- 05 Nov 2013 New trial record